Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S (NOVO B)
Mes derničres consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novo Nordisk A/S
Develops, manufactures, markets and distributes pharmaceutical products

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products.

It operates through the Diabetes and Obesity Care; and Biopharmaceuticals segments.

The Diabetes and Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity.

The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy.

The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsvćrd, Denmark.

Number of employees : 41 971 persons.
Sales per Businesses
20152016Delta
DKK (in Million)%DKK (in Million)%
Diabetes & Obesity Care85,59079.3%88,94979.6% +3.92%
Biopharmaceuticals22,33720.7%22,83120.4% +2.21%
Sales per Regions
20152016Delta
DKK (in Million)%DKK (in Million)%
North America56,85752.7%---
Europe20,79819.3%20,68218.5% -0.56%
International14,96613.9%14,05012.6% -6.12%
Region China9,8719.1%10,4589.4% +5.95%
Japan & Korea5,4355%---
United States--57,19451.2%-
Pacific--9,3968.4%-
Managers
NameAgeSinceTitle
Lars Fruergaard Jřrgensen, MBA511991President & Chief Executive Officer
Göran Ando682005Chairman
Maziar Mike Doustdar471992Executive Vice President-International Operations
Jesper Brandgaard, MBA541999Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen, PhD571991Chief Science Officer & Executive Vice President
Anne Marie Handrup Kverneland611981Director
Stig Strřbćk531992Director
Elizabeth Anne Hewitt612012Independent Director
Sřren Thuesen Pedersen, MBA531994Director
Jeppe Fonager Christiansen582013Vice Chairman
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,012,564,000 1,753,082,748 87.1% 45,667,252 2.3% 68.7%
Share B 10 537,436,000 0 0.0% 0 0.0%
Shareholders
NameEquities%
Novo Nordisk Fonden 163,814,000 8.35%
Novo Nordisk A/S 48,050,383 2.45%
Norges Bank Investment Management 42,958,316 2.19%
The Vanguard Group, Inc. 42,491,674 2.17%
Alecta Pension Insurance Mutual 28,698,000 1.46%
Capital Research & Management Co. (World Investors) 24,911,414 1.27%
BlackRock Fund Advisors 19,536,983 1.00%
Flossbach von Storch AG 18,016,800 0.92%
Jupiter Asset Management Ltd. 17,141,763 0.87%
Northern Cross LLC 15,948,341 0.81%
Holdings
NameEquities%Valuation
Novo Nordisk A/S (NOVO B) 48,050,3832.45%2,390,633,407 USD
Nnit A/S (NNIT) 6,375,00025.5%181,641,026 USD
Innate Pharma (IPH) 8,908,45615.5%97,137,181 USD
Pieris Pharmaceuticals Inc (PIRS) 0
Company contact information
Novo Nordisk A/S
Novo Allé
Bagsvćrd, Capital Region 2880

Phone : +45.44.44.88.88
Web : www.novonordisk.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
NOVO NORDISK A/S29.01%102 274
JOHNSON & JOHNSON20.08%368 832
NOVARTIS12.75%219 874
ROCHE HOLDING LTD.4.90%215 394
PFIZER9.42%211 188
MERCK AND COMPANY-7.64%148 286
AMGEN16.16%123 376
SANOFI-0.25%114 646
BAYER9.45%106 161
BRISTOL-MYERS SQUIBB COMPANY4.79%100 068
ABBOTT LABORATORIES45.27%97 126
ELI LILLY AND COMPANY13.54%92 140
GLAXOSMITHKLINE-16.61%85 349
ASTRAZENECA12.83%83 904
CELGENE CORPORATION-9.72%82 794
ALLERGAN PLC-18.73%58 146
SHIRE-19.90%45 128
TAKEDA PHARMACEUTICAL CO LTD27.30%43 754
JIANGSU HENGRUI MEDICINE CO LTD52.11%29 368
CHUGAI PHARMACEUTICAL CO LTD67.51%28 271
ASTELLAS PHARMA INC-12.88%26 339
Connections : Novo Nordisk A/S
Fondsmćglerselskabet Maj Invest A/S
University of Copenhagen
Harno Invest A/S
Archimedes Pharma UK Ltd.
Hofor Forsyning Komplementar A/S
Bio*One Capital Pte Ltd.
Novo Nordisk China Pharmaceuticals Co. Ltd.
EUSA Pharma (Europe) Ltd.
EUSA Pharma (UK) Ltd.
RAND Health
The International Centre for Missing & Exploited Children
Haldor Topsoe A/S
Novo Holdings A/S
Essex Woodlands Health Ventures UK Ltd.
Novo Nordisk Holding Ltd.
SWMF Life Science Venture Fund LP
Steno Diabetes Center A/S
NNE Pharmaplan A/S
Novo Nordisk Fonden
Melrose Holdings Plc
Novo Nordisk Region Japan & Korea A/S
Silverwood Property Ltd.
Novo Nordisk Region Europe A/S
HOFOR Forsyning Holding A/S
Novo Nordisk Region International Operations A/S
Hofor Forsyning A/S
Novo Nordisk Gsc Holding A/S
Fondsmćglerselskabet Maj Invest A/S (Broker)
Novo Nordisk Pharmaceuticals A/S
Maj Invest Holding A/S
Novo Nordisk Invest 2 A/S
Novo Nordisk Region China A/S
Novo Nordisk Region North America Ii A/S
SC Triton Industry SRL
© 2017 People , Fundamentals and Ownership